November 5, 2021
Health IT
  • Google parent company Alphabet Inc. launched a new firm to use artificial intelligence to “reimagine the entire drug discovery process from the ground up.” The company, called Isomorphic Labs, will build off of work from Alphabet’s research lab that has used algorithms to make advances in predicting the shapes of proteins. The company aims to help identify new drugs and build models that can predict how drugs will interact with the body. (Articles here, here, and here)